GGrantIndex
Sort

46,585 grants matching heart failure

Personalized oxygen therapy for critically ill adults: a randomized trial

$874,997
Matthew Wall Semler · Vanderbilt University Medical Center · R61 · FY2025 · HL

CHARACTERIZATION OF TRPC6 TO PREDICT AND PREVENT CHEMOTHERAPY-RELATED CARDIOMYOPATHY AND HEART FAILURE IN WOMEN

$874,988
Mayo Clinic Jacksonville (A Nonprofit Corporation) · · FY2022 · Department of the Army

Studies in pig-to-primate cardiac xenotransplantation

$874,047
Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2006 · AI

Control Mechanisms for Matching ATP Supply and Demand in Heart Mitochondria

$874,030
Steven Sollott · National Institute On Aging · ZIA · FY2019 · AG

Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH

$873,988
Suman Srinivasa · Massachusetts General Hospital · R01 · FY2020 · HL

1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

$873,890
Gustavo Adolfo Heresi Davila · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2025 · HL

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

$873,736
Anoopindar Bhalla · Children'S Hospital Of Los Angeles · R01 · FY2024 · HL

S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease mark

$873,517
Michael R Pisano · Accord Biomaterials, Inc. · R44 · FY2011 · HL

Ventricular Dynamics from Surgically Inserted Markers

$873,295
Stanford University · R01 · FY2005 · HL

A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events

$873,210
Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL

Atherosclerosis Risk in Communities Study (ARIC)

$873,084
Christie M Ballantyne · Baylor College Of Medicine · N01 · FY2009 · HL

Development of a Total Artificial Lung

$873,049
University Of Michigan At Ann Arbor · R01 · FY2003 · HL

Mechanical circulatory support: Measures of adjustment and quality of life

$873,012
Kathleen L Grady · Northwestern University At Chicago · R01 · FY2016 · HL

Molecular Imaging of Primary Amyloid Cardiomyopathy

$872,796
Sharmila Dorbala · Brigham And Women'S Hospital · R01 · FY2016 · HL

Late Effects in Wilms Tumor Survivors and Offspring

$872,785
Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA

NIDA Clinical Trials Network: Big South/West Node

$872,759
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2025 · DA

Development of a Mucosal Nanoemulsion-Adjuvanted RSV Vaccine using Recombinant Pre-Fusion F Protein

$872,585
Kevin Trabbic · Bluewillow Biologics, Inc. · R44 · FY2023 · AI

CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES

$872,312
Kalyanam Shivkumar · University Of California Los Angeles · OT2 · FY2019 · OD

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

$872,054
Anand Vaidya · Brigham And Women'S Hospital · R01 · FY2023 · HL

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

$872,054
Anand Vaidya · Brigham And Women'S Hospital · R01 · FY2022 · HL

Single cell, whole genome analysis of the aging human cardiomyocyte

$871,975
Sangita Choudhury · Boston Children'S Hospital · R01 · FY2022 · HL

Mesenchymal stem cell enhancement of organ allograft repair and long term surviva

$871,951
Amelia M. Bartholomew · University Of Miami School Of Medicine · P01 · FY2012 · AI

IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - CORE STUDY OPERATIONS

$871,825
Aaron Folsom · University Of Minnesota · N01 · FY2020 · HL

Health Effects Of Exposures In Agriculture

$871,724
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES

Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)

$871,361
Jordan Blair Strom · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL